Nasacort (Triamcinolone Acetonide)

Triamcinolone Acetonide, the active ingredient in Nasacort, is a glucocorticoid corticosteroid presented as a nasal spray for intranasal administration. It reduces inflammation of the nasal mucosa and is indicated for the relief of allergic rhinitis and seasonal nasal allergy symptoms in both adult and pediatric patients.

GNH USA supplies Nasacort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The company ensures quality compliance with EU pharmacopeial standards and offers flexible shipment options.

Nasacort, a nasal corticosteroid, acts on inflammatory pathways of the nasal mucosa to relieve allergy‑related symptoms.

Allergic rhinitis: reduces nasal congestion, itching, and sneezing. Seasonal nasal allergy: alleviates symptoms triggered by pollen or mold exposure. Perennial allergic rhinitis: provides year‑round control of nasal allergy symptoms.

Nasacort may cause local or systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Nosebleeds (epistaxis). - Headache. - Throat irritation or cough. - Unpleasant taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Vision changes or cataract formation. - Severe allergic reaction (anaphylaxis). - Elevated intraocular pressure. - Fungal infection of the nasal passages. - Suppression of the hypothalamic‑pituitary‑adrenal axis.

Before using Nasacort, consider the following safety measures.

Pregnancy: consult a healthcare provider before use. Pediatric use: safety established for children aged 2 years and older. Concurrent infection: avoid use if an active nasal infection is present. Surgery: discontinue prior to nasal or sinus surgery as advised by the surgeon. Avoid overuse: do not exceed the recommended frequency. Store at room temperature: keep in the original container, protect from moisture and heat.

Nasacort can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors: may raise local drug exposure. - Live vaccines: nasal steroid may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles: may modestly increase nasal exposure. - Ritonavir or other protease inhibitors: may increase local concentration. - Nasal decongestants: concurrent use may heighten local irritation.